Cabozantinib 40mg Tablets

Cabozantinib 40mg Tablets contain cabozantinib, a targeted anticancer medicine classified as a tyrosine kinase inhibitor. Cabometyx 40mg is a branded film-coated tablet formulation used in specialist oncology treatment.

Customers searching for Cabozantinib 40mg price, Cabometyx 40mg tablets, oncology pharmacy supply or product availability should verify current pricing, packaging and dispensing requirements with an authorized pharmacy.

Product Information

Why Choose Cabozantinib 40mg Tablets?

• Recognized brand reference: Cabometyx 40mg.

• Specified strength: 40mg cabozantinib.

• Established oncology formulation: Used in approved specialist treatment regimens.

• Product verification: Confirm manufacturer, tablet strength and packaging before purchase.

• International supply enquiries: Verify authorized availability in the destination market.

Cabozantinib 40mg Price and Ordering Information

The price of Cabozantinib 40mg tablets varies by country, healthcare coverage, supplier and pack size. Contact an authorized oncology pharmacy to confirm the current Cabometyx 40mg price, stock availability and prescription requirements.

Before ordering, verify the product registration, packaging, expiry date and legal dispensing conditions. Cabozantinib is a specialist prescription medicine and should not be purchased from unauthorized suppliers.

Generic Cabozantinib 40mg vs Cabometyx 40mg

Cabometyx 40mg is a branded tablet containing cabozantinib. Other cabozantinib products must not automatically be described as equivalent, because formulations and regulatory authorizations can differ.

Confirm the active ingredient, dosage form, strength, manufacturer and local registration before considering a product substitution.

Cabozantinib 40mg — Availability by Country

Cabozantinib 40mg is used in certain prescribed treatment regimens, including combination treatment with nivolumab for advanced renal cell carcinoma under applicable US prescribing information. It may also be used as a reduced dose when the oncologist adjusts treatment for tolerability or other clinical considerations.

Dosage varies by cancer indication, treatment combination and local product label. Do not change the prescribed dose without the treating oncologist's direction.

Cabozantinib can cause serious adverse reactions, including severe bleeding, high blood pressure, blood clots, gastrointestinal perforation, impaired wound healing and liver problems. Common adverse effects can include diarrhoea, fatigue, nausea, reduced appetite and hand-foot skin reactions.

Regular clinical monitoring is essential. Inform the oncology team about other medicines, supplements, planned surgery and existing medical conditions before treatment.